Algatech licenses technology to extract beta-glucans from Euglena gracilis microalgae
Algatech Ltd. has licensed the rights and intellectual property of technology belonging to F3 Platform Biologics that is designed to extract β-1,3-glucans from Euglena gracilis microalgae.
At Algatech our vision is to make an impact by bringing the good that’s in microalgae to the world. We work relentlessly to elevate the well-being of humans and animals with our products and grow our business with the same honesty and integrity we use to craft our state-of-the-art nutrients, utilizing cutting edge ecofriendly technologies and innovative science. This is our blog.